Protein Kinase CK2 and Epstein–Barr Virus

Protein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In genera...

Full description

Bibliographic Details
Main Authors: Mathias Montenarh, Friedrich A. Grässer, Claudia Götz
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/2/358
_version_ 1827758499809984512
author Mathias Montenarh
Friedrich A. Grässer
Claudia Götz
author_facet Mathias Montenarh
Friedrich A. Grässer
Claudia Götz
author_sort Mathias Montenarh
collection DOAJ
description Protein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In general, viruses use host signaling mechanisms for the replication of their genome as well as for cell transformation leading to cancer. Therefore, it is not surprising that CK2 also plays a role in controlling viral infection and the generation of cancer cells. Epstein–Barr virus (EBV) lytically infects epithelial cells of the oropharynx and B cells. These latently infected B cells subsequently become resting memory B cells when passing the germinal center. Importantly, EBV is responsible for the generation of tumors such as Burkitt’s lymphoma. EBV was one of the first human viruses, which was connected to CK2 in the early nineties of the last century. The present review shows that protein kinase CK2 phosphorylates EBV encoded proteins as well as cellular proteins, which are implicated in the lytic and persistent infection and in EBV-induced neoplastic transformation. EBV-encoded and CK2-phosphorylated proteins together with CK2-phosphorylated cellular signaling proteins have the potential to provide efficient virus replication and cell transformation. Since there are powerful inhibitors known for CK2 kinase activity, CK2 might become an attractive target for the inhibition of EBV replication and cell transformation.
first_indexed 2024-03-11T09:07:12Z
format Article
id doaj.art-ac45635c9f5d4d0caecb368ac4e943cc
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T09:07:12Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-ac45635c9f5d4d0caecb368ac4e943cc2023-11-16T19:17:02ZengMDPI AGBiomedicines2227-90592023-01-0111235810.3390/biomedicines11020358Protein Kinase CK2 and Epstein–Barr VirusMathias Montenarh0Friedrich A. Grässer1Claudia Götz2Medical Biochemistry and Molecular Biology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyInstitute of Virology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyMedical Biochemistry and Molecular Biology, Saarland University, Buildings 44 and 47, 66424 Homburg, GermanyProtein kinase CK2 is a pleiotropic protein kinase, which phosphorylates a number of cellular and viral proteins. Thereby, this kinase is implicated in the regulation of cellular signaling, controlling of cell proliferation, apoptosis, angiogenesis, immune response, migration and invasion. In general, viruses use host signaling mechanisms for the replication of their genome as well as for cell transformation leading to cancer. Therefore, it is not surprising that CK2 also plays a role in controlling viral infection and the generation of cancer cells. Epstein–Barr virus (EBV) lytically infects epithelial cells of the oropharynx and B cells. These latently infected B cells subsequently become resting memory B cells when passing the germinal center. Importantly, EBV is responsible for the generation of tumors such as Burkitt’s lymphoma. EBV was one of the first human viruses, which was connected to CK2 in the early nineties of the last century. The present review shows that protein kinase CK2 phosphorylates EBV encoded proteins as well as cellular proteins, which are implicated in the lytic and persistent infection and in EBV-induced neoplastic transformation. EBV-encoded and CK2-phosphorylated proteins together with CK2-phosphorylated cellular signaling proteins have the potential to provide efficient virus replication and cell transformation. Since there are powerful inhibitors known for CK2 kinase activity, CK2 might become an attractive target for the inhibition of EBV replication and cell transformation.https://www.mdpi.com/2227-9059/11/2/358protein kinase CK2phosphorylationEpstein–Barr virusEBV-encoded proteinssignaling pathwaysp53
spellingShingle Mathias Montenarh
Friedrich A. Grässer
Claudia Götz
Protein Kinase CK2 and Epstein–Barr Virus
Biomedicines
protein kinase CK2
phosphorylation
Epstein–Barr virus
EBV-encoded proteins
signaling pathways
p53
title Protein Kinase CK2 and Epstein–Barr Virus
title_full Protein Kinase CK2 and Epstein–Barr Virus
title_fullStr Protein Kinase CK2 and Epstein–Barr Virus
title_full_unstemmed Protein Kinase CK2 and Epstein–Barr Virus
title_short Protein Kinase CK2 and Epstein–Barr Virus
title_sort protein kinase ck2 and epstein barr virus
topic protein kinase CK2
phosphorylation
Epstein–Barr virus
EBV-encoded proteins
signaling pathways
p53
url https://www.mdpi.com/2227-9059/11/2/358
work_keys_str_mv AT mathiasmontenarh proteinkinaseck2andepsteinbarrvirus
AT friedrichagrasser proteinkinaseck2andepsteinbarrvirus
AT claudiagotz proteinkinaseck2andepsteinbarrvirus